glp-1 dual agonist Schematic illustration of monoagonists, agonists and triple Current Insights, Advantages and Challenges

What Are GLP-1 Medications and How Do They Work

This higher dose is specifically designed to enhance its weight loss effects

Future research should prioritize long-term safety assessments, efficacy evaluations in specific populations, exploration of novel indications (eg, metabolic-associated fatty liver disease and obstructive sleep apnea), and mechanistic studies to enhance the therapeutic utility of these agents in metabolic and related diseases (See Figure 7)

Stimulating insulin secretion: GLP-1 helps the pancreas release insulin in response to food, which helps lower blood sugar levels

Replacement with Tyr 7 lowers both the affinity (IC 50 : 0.26 nM2.7 nM) and activity (EC 50 : 0.8 nM5.4 nM)

What it means for consumers: It's unclear which insurance markets or patients the $149 price tag would apply to